Nahdi Medical Company

Equities

4164

SA15HG521213

Drug Retailers

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
135.8 SAR -0.15% Intraday chart for Nahdi Medical Company -3.14% -0.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nahdi Medical Posts Higher FY23 Net Profit, Revenue MT
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023 CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
OptiBiotix says market still "volatile" but partner sales improving AN
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources RE
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023 CI
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
OptiBiotix Health gets approval to sell products in Saudi Arabia AN
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome CI
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries CI
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022. CI
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index CI
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite CI
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022 CI
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index CI
Nahdi Medical Company has completed an IPO in the amount of SAR 5.109 billion. CI
Nahdi Medical Company has filed an IPO. CI
OptiBiotix Health plc Signs Exclusive Sales and Distribution Agreement with Nahdi Medical Co CI
Chart Nahdi Medical Company
More charts
Al Nahdi Medical Company SJSC is a Saudi Arabia-based retail pharmacy and healthcare company. The Company is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The Company operates two operating segments: Front Shop and Pharma. The Company provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The Company provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The Company operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Company’s subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
135.8 SAR
Average target price
155.4 SAR
Spread / Average Target
+14.46%
Consensus
  1. Stock Market
  2. Equities
  3. 4164 Stock
  4. News Nahdi Medical Company
  5. Nahdi Medical Posts Higher FY23 Net Profit, Revenue